Engineered immune cells recognise, attack human and mouse solid-tumour cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and…
Browsing: Leukaemia
Decades old mystery in leukaemia treatment solved
A research team led by the University of Kent and Goethe-University Frankfurt am Main, Germany,…
Blood cell mutations linked to leukaemias are inevitable as we age
A new study by researchers at the RIKEN Center for Integrative Medical Science in Japan…
Targeting stem cells: The path to curing poor-prognosis leukaemia
Researchers at Children’s Cancer Institute Australia have discovered what could prove a new and improved…
Nanoparticle for overcoming leukemia treatment resistance
UConn associate professor of pharmaceutics Xiuling Lu, along with professor of chemistry Rajeswari M. Kasi,…
Blood cancer find raises new treatment hopes
New QIMR Berghofer research has identified how an early genetic change in blood and bone…
EHA 2020: Advances in treatment of high-risk chronic lymphocytic leukaemia
Prognosis in high risk Chronic Lymphocytic Leukemia (CLL) is still unsatisfactory. Despite the availability of…
EHA 2020: Gut microbiome disturbance by antibiotic treatment early in life is sufficient to induce leukaemia in predisposed mice
Genetic predisposition to childhood leukaemia is frequent (>1-5%), but less than 1% of genetic carriers…
EHA 2020: A paradigm shift for the treatment of newly diagnosed older acute myeloid leukaemia patients
Acute myeloid leukaemia (AML) is primarily a disease of older adults. Standard commonly utilised lower-intensity…
EHA 2020: Combined irradiation and chemotherapy better prepares children for stem cell transplantation than chemotherapy alone
Treatment of childhood cancer is a success story, particularly for acute lymphoblastic leukaemia (ALL). More…